Ubs Asset Management Americas Inc Karuna Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

$277 Billion
Q1 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$161.01 - $317.85 $2.77 Million - $5.46 Million	-17,189 Reduced 10.89%	140,675 $44.5 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $3.44 Million - $4.55 Million	20,886 Added 15.25%	157,864 $26.7 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $4.54 Million - $5.76 Million	28,166 Added 25.89%	136,978 $24.9 Million
Q4 2022 Feb 14, 2023	BUY	$191.53 - $236.82 $624,196 - $771,796	3,259 Added 3.09%	108,812 $21.4 Million
Q3 2022 Nov 14, 2022	SELL	$123.79 - $277.42 $7.32 Million - $16.4 Million	-59,156 Reduced 35.92%	105,553 $23.7 Million

Q2 2022 Aug 12, 2022	SELL	$93.97 - $143.33 $7.38 Million - $11.3 Million	-78,517 Reduced 32.28%	164,709 $20.8 Million
Q1 2022 May 16, 2022	BUY	$98.9 - $132.37 $275,238 - $368,385	2,783 Added 1.16%	243,226 $30.8 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $2.64 Million - $3.81 Million	23,880 Added 11.03%	240,443 $31.5 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $1.35 Million - $1.68 Million	-13,314 Reduced 5.79%	216,563 $26.5 Million
Q2 2021 Aug 16, 2021	SELL	$107.45 - $135.95 $57,808 - $73,141	-538 Reduced 0.23%	229,877 $26.2 Million
Q1 2021 May 14, 2021	SELL	$95.46 - $133.08 $1.72 Million - $2.4 Million	-18,010 Reduced 7.25%	230,415 $27.7 Million
Q4 2020 Mar 01, 2021	BUY	$75.23 - $109.23 $1.78 Million - $2.58 Million	23,658 Added 10.53%	248,425 $25.2 Million
Q3 2020 Nov 13, 2020	SELL	$71.31 - $109.74 $16,686 - $25,679	-234 Reduced 0.1%	224,767 $17.4 Million
Q2 2020 Aug 14, 2020	BUY	$62.14 - $117.21 $4.08 Million - $7.69 Million	65,578 Added 41.13%	225,001 $25.1 Million
Q1 2020 May 15, 2020	BUY	$60.41 - $115.92 $9.63 Million - $18.5 Million	159,423 New	159,423 $11.5 Million

Others Institutions Holding KRTX

# of Institutions

Shares Held

333K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account